Lyell Immunopharma shares owned by Foresite Capital Management IV
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Foresite Capital Management IV
from 13F filings
Historical chart of Foresite Capital Management IV investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by Foresite Capital Management IV consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by Foresite Capital Management IV
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $13M | 8.8M | 1.47 |
| 2023-06-30 | $31M | 9.7M | 3.18 |
| 2023-03-31 | $24M | 10M | 2.36 |
| 2022-12-31 | $35M | 10M | 3.47 |
| 2022-09-30 | $73M | 10M | 7.33 |
| 2022-06-30 | $87M | 13M | 6.52 |
| 2022-03-31 | $67M | 13M | 5.05 |
| 2021-12-31 | $103M | 13M | 7.74 |
| 2021-09-30 | $197M | 13M | 14.80 |
| 2021-06-30 | $216M | 13M | 16.24 |
More positions owned by Foresite Capital Management IV
View all positions for Foresite Capital Management IV